Byron B. Rooney

Davis Polk advised XP Inc. on its $1.23 billion equity offering of 31,654,894 Class A common shares, consisting of 7,130,435 shares sold by XP and 24,524,459 shares sold by ITB Holding…

We advised the initial purchasers on the high-yield notes offering

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $175.8 million initial public offering of 10,637,500 shares of Class A…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Genuine Parts Company of $500 million aggregate principal amount of its 1.875% senior…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered debt issuance by H.B. Fuller Company of $300 million of its 4.250% notes due 2028…

Davis Polk advised Pactiv Evergreen Inc. on a Rule 144A/Regulation S offering of $1.0 billion aggregate principal amount of its 4.000% senior notes due 2027 by Reynolds Group Issuer Inc…

Davis Polk advised Nuvei Corporation in connection with its initial public offering of 30,961,539 subordinate voting shares for an aggregate amount of approximately $805 million. The…

Davis Polk advised Pactiv Evergreen Inc. (formerly known as Reynolds Group Holdings Limited) on its $574 million initial public offering of 41,026,000 shares of common stock. The shares of…

Davis Polk advised  the representatives of the underwriters on an SEC-registered offering by Schlumberger Finance Canada Ltd. of $500 million aggregate principal amount of 1.400%…

Davis Polk advised Truist Ventures, the corporate venture capital division of Truist Financial Corporation, on its lead role in a $31 million strategic funding round in Veem. This…